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INTRODUCTION
Psoriasis is a common inflammatory skin disease characterized by red and scaling skin plaques. Patients with psoriasis are at higher risk of multiple comorbidities, including diabetes, cardiovascular diseases, psoriatic arthritis, Crohn's disease, lymphomas and depression, and as a result, have a shorter lifespan (Armstrong et al., 2015; Guttman-Yassky et al., 2011a) . Th1, Th17 and Th22 cells and cytokines they produce have been suggested to be responsible for the development of the inflammatory environment and characteristic hyperproliferation of keratinocytes in psoriasis (Guttman-Yassky et al., 2011b; Krueger, 2012) . Recent clinical studies, in which psoriasis patients were successfully treated with different IL-17 antagonists, point out the pivotal role of IL-17 in the pathogenesis of psoriasis (Griffiths et al., 2015; Langley et al., 2014; Papp et al., 2012a; Papp et al., 2012b) . Genetic studies demonstrate that psoriasis is associated with markers near genes involved in Th17 differentiation and responsiveness, for example, IL23R, RUNX3 and STAT3 (Kim et al., 2015; Tsoi et al., 2012) as well as genes from the NF-κB signaling pathway regulating innate immune responses, such as CARD14, CARM1 and NFKBIZ (Baurecht et al., 2015; Tsoi et al., 2015; Tsoi et al., 2012) . microRNAs (miRNAs) are gene expression regulators that trigger target mRNA degradation and inhibit translation and thereby regulate most of the biological processes in higher eukaryotes (Boldin et al., 2012; Izaurralde, 2015) . The miR-146 family consists of two members, miR-146a and miR-146b (miR146a/b), which are encoded by independent genes located on human chromosomes 5 and 10, respectively. Mature miR-146a/b differ from each other in only two nucleotides, which suggests that they target very similar sets of transcripts (Taganov et al., 2006) . Both miR-146a/b have been shown to be upregulated in the skin of psoriasis patients (Lovendorf et al., 2015; Sonkoly et al., 2007) . Numerous studies demonstrate that miR-146a has an anti-inflammatory function. The expression of miR-146a is upregulated by NF-κB and it directly inhibits several factors from the NF-κB pathway, including IL-1 receptor-associated kinase 1 (IRAK1) (Taganov et al., 2006) and caspase recruitment domain-containing M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 5 protein 10 (CARD10) (Crone et al., 2012; Rebane et al., 2014) . miR-146a-/-mice develop autoimmunity caused by the incapacity of T regulatory (Treg) cells to suppress Th1 type responses (Boldin et al., 2011; Lu et al., 2010) . In human primary keratinocytes, miR-146a inhibits the expression of many proinflammatory factors, including CCL5 and IL-8 (Meisgen et al., 2014; Rebane et al., 2014) . miR-146a has been shown to act as anti-inflammatory miRNA in mouse models of AD (Rebane et al., 2014) , irritant contact dermatitis (Urgard et al., 2016) and psoriasis (Srivastava et al., 2016) . The single nucleotide polymorphism (SNP) rs2910164 located in miR-146a precursor has been suggested to be associated with psoriasis in Han Chinese population (Zhang et al., 2014) and among Caucasians (Srivastava et al., 2016) .
The expression of miR-146b has been shown to be activated by the signal transducer and activator of transcription (STAT)3 (Curtale et al., 2013) . The functions of miR-146b are less described, however, considering high similarity, miR-146a/b seem to have important and complementary role in proper functioning of immune system (Ahn et al., 2013; Curtale et al., 2013 ).
In the current study, we analyzed the expression of miR-146a/b and target genes in the skin of patients with plaque psoriasis, investigated the functions and the expression regulation of miR-146a/b in keratinocytes and fibroblasts, and explored the association of single nucleotide polymorphisms (SNPs) in miR-146a/b and selected target genes with psoriasis. Our results indicate that besides miR-146a, miR146b may play a role in the maintenance of skin homeostasis and the regulation of inflammatory responses and keratinocyte proliferation in psoriatic skin.
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RESULTS
The expression of miR-146a/b in keratinocytes and in the skin of psoriasis patients
Previous miRNA profiling studies have suggested increased expression of miR-146a/b in lesional skin of psoriasis patients (Lovendorf et al., 2015; Sonkoly et al., 2007) . First, we confirmed by RT-qPCR that miR146a/b are more highly expressed in lesional as compared to non-lesional skin of psoriasis patients and the skin of control individuals (Figure 1a , Supplementary Table S1 ), however, no correlation with psoriasis severity was found (see Supplementary Figure S1 online). The expression levels of miR-146a/b were higher in the skin as compared to cultured primary keratinocytes and fibroblasts, but lower than in peripheral blood mononuclear cells (PBMCs) (Figure 1b ). The expression of miR-146a was about 2.4-fold higher than miR-146b in control skin samples ( Figure 1c) . In situ hybridization (ISH) analysis showed increased expression of miR-146a in the skin from psoriasis patients with the highest staining in the stratum spinosum area of the epidermis in the psoriatic lesional skin. The miR-146b signal was weaker than that of miR-146a and was detected in both the epidermis and the dermis of lesional skin of psoriasis patients (Figure 1d ). miR-146a was induced by IL-1β, TNF-α and IL-17A in human proliferating keratinocytes, in 3D reconstituted epidermis and in fibroblasts (Figure 1e-g ). miR-146b expression was increased in response to IFN-γ in keratinocytes and in reconstituted epidermis ( Figure 1e ) and in response to IL-22 only in reconstituted epidermis (Figure 1f ) where the expression of IL-22 receptor components IL10RB and IL22RA1 (Akdis et al., 2016) were increased (Supplementary Figure S2a) . In fibroblasts, the expression of miR-146b was moderately enhanced in response to IL-1β (Figure 1g) .
Genes regulated by miR-146a are differentially expressed in the skin of psoriasis patients
We next tested whether the expression of miR-146a-influenced inflammation-related genes is changed in the skin of psoriasis patients. Figure 2a demonstrates that IRAK1, CCL5 and IL-8 were upregulated, and CARD10 was downregulated in lesional skin of psoriasis patients. To identify other psoriasis-related
processes influenced by miR-146a, we performed pathway analysis of published array data (Rebane et al., 2014) and found that the genes involved in the regulation of cell proliferation are enriched among the set of 102 genes downregulated by miR-146a in unstimulated keratinocytes. Most of these genes were also suppressed by miR-146a in keratinocytes stimulated with TNF-α and IFN-γ (Figure 2b , Supplementary Tables S2 online). Using Targetscan-based search approach, we identified that five of these genes were putative or previously published direct targets of miR-146a (Figure 2b and Supplementary Table S3 online). Among these, a novel proliferation-associated putative direct target fermitin family member 1 (FERMT1, also known as kindlin-1) was found to be increased in non-lesional and lesional skin of psoriasis patients. Earlier verified miR-146a direct target, NUMB (Hung et al., 2013) was enhanced in lesional skin of psoriasis patients (Figure 2c ). The relative levels of miR-146a/b and the target genes revealed no significant correlation in psoriatic lesional skin (Supplementary Figure S3) . miR-146a inhibits the proliferation of human primary keratinocytes miR-146a has been shown to suppress viability of keratinocytes in a cell counting assay, in which the impact on proliferation and cell death cannot be discriminated (Zhang et al., 2014) . To more precisely describe miR-146a effect, we transfected keratinocytes with miR-146a mimics and performed both the proliferation and cell death assays. Figure 3a demonstrates that the overexpression of miR-146a strongly reduced the proliferation of unstimulated keratinocytes and the inhibition of miR-146a increased keratinocyte proliferation in used conditions (Figure 3b ). In the subsequent cell death assay, we did not detect difference in unstimulated cells transfected with miR-146a or the control. Pro-inflammatory cytokines TNF-α and IFN-γ caused activation-induced cell death as then about 11% of the control transfected cells were detected Annexin-V positive, which was reduced when miR-146a was transfected 
FERMT1 is a direct target of miR-146a
Among genes suppressed by miR-146a, FERMT1 is known as a positive regulator of keratinocyte proliferation needed for formation of normal skin structure (Duperret et al., 2014; Herz et al., 2006) .
Using Targetscan, we found two miR-146a binding sites located within the 3' untranslated region (3' UTR) of FERMT1 mRNA (Figure 4a ), which we inserted together with flanking areas into the luciferase reporter vector and performed luciferase assays. As presented in Figure 4b (Figure 4f ), while the keratinocyte differentiation marker Keratin 10 (KRT10) was more highly expressed in stratum spinosum. These results demonstrate that FERMT1 is a direct target of miR-146a and has increased expression in psoriatic skin.
miR-146b inhibits psoriasis-associated miR-146a target genes and proliferation of primary keratinocytes
Mature miR-146b differs from miR-146a in two nucleotides that are located outside the seed area, which suggests that miR-146a/b target very similar set of genes. Thus, we next transfected keratinocytes Figure S6) . Similarly to miR-146a, the transfection of miR-146b led to the suppression of proliferation of keratinocytes ( Figure 5b ).
Association analysis of MIR146A and target gene variants with psoriasis
To investigate whether psoriasis is associated with genetic variations within or close to miR-146a/b encoding genes (MIR146A and MIR146B) and previously verified direct target genes IRAK1, CARD10, CCL5 and NUMB (Crone et al., 2012; Hung et al., 2013; Rebane et al., 2014; Taganov et al., 2006) as well as FERMT1, we carried out in silico candidate gene analysis using existing genome-wide association studies (GWAS) data (Baurecht et al., 2015) . The in silico analysis showed suggestive evidence for presence of two independent psoriasis susceptibility loci in the MIR146A gene region. One marker mapped 853 bp upstream from miR-146a encoding sequence, with the lead variant rs2961920 (OR=1.12, P=0.0015) being in perfect linkage disequilibrium (LD) (r 2 =1) with a functional polymorphism rs2910164 (Luo et al., 2011) reported to be associated with various autoimmune diseases (Li et al., 2015) and with psoriasis in Han Chinese population with the same effect direction (Zhang et al., 2014 ). An independent association was observed for rs184776122 (OR=0.80, P = 0.005) 37 kb downstream of the MIR146A gene (Supplementary Table S4 online). Recently, rs2910164-CC genotype was reported to have a protective association with psoriasis in HLA-C*06 (a main risk allele in psoriasis) negative patients with Caucasian origin (Srivastava et al., 2016) . We performed similar association analysis as well as stratification by HLACw*0602 using our dataset. We observed a significant protective effect of the rs2910164-C allele with M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 10 similar effect size as reported in (Srivastava et al., 2016) . In contrast, we could not confirm the protective recessive effect of rs2910164-CC and instead observed a protective heterozygote effect of rs2910164-GC (Supplementary Table S5 ). Stratified analysis by HLA-Cw*0602 showed the mentioned rs2910164-C and the rs2910164-GC effects above in both strata (Supplementary Table S5 ). Analysis of the combination of HLA-Cw*0602 and rs2910164 as proposed by Srivastava et al. revealed the wellknown strong association of HLA-Cw*0602 with psoriasis and an additional moderate protective effect of rs2910164-GC genotype in both HLA-Cw*0602 positive and negative patients (Supplementary Table   S5 ). Out of the 5 target genes, only rs7293163, mapped to the cell division cycle 42 effector protein (CDC42EP1) gene close to the CARD10 gene, showed a moderate association with psoriasis (OR=1.14, P = 0.00017) (Supplementary Table S4 online).
The regulation of miR-146a/b and target genes
To study the capacity of endogenous miR-146a/b to modulate their target genes, we next performed a series of experiments with human and mouse keratinocytes. The stimulation with psoriasis-related cytokines TNF-α, IL-17A and IFN-γ revealed that miR-146a/b targets are more strongly induced at early (6, 12 and 24 h) and miR-146a/b at late (48 or 72 h) time-points, when the targets were reduced (CCL5 and IL-8) or stimulated to lesser extent (FERMT1) in human keratinocytes (Supplementary Figure S7) . As expected, in most of the conditions, the LNA inhibitor targeting both miR-146 family members lead to the increased expression of the target genes in unstimulated keratinocytes and in the cells stimulated with TNF-α and IL-17A (Supplementary Figure S8) . To distinguish the effect of miR-146a and miR-146b, we then used keratinocytes and skin fibroblasts from wild type (WT), miR-146a-/-and miR-146b-/-mice (Supplementary Figure S9a Figure 10b) . As similarly to the human fibroblasts, the expression of Fermt1 and Numb1 was almost undetectable in mouse skin fibroblasts, these genes were excluded from the analysis.
DISCUSSION
Lesional skin in psoriasis is characterized by persistent inflammation and hyperproliferation of keratinocytes, however, the molecular mechanisms behind these features are still not fully understood.
The function of miR-146a in psoriasis and association of the single nucleotide polymorphism (SNP) rs2910164 located in miR-146a precursor has been studied before (Srivastava et al., 2016; Zhang et al., 2014 ). In the current study, we demonstrate that besides miR-146a, miR-146b is expressed and probably able to regulate inflammatory responses in keratinocytes and skin fibroblasts and thereby may influence the pathogenesis of psoriasis. In addition, we show that a positive regulator of keratinocyte M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 12 proliferation, FERMT1 is a direct target of miR-146a and that the effect of miR-146a on keratinocyte proliferation is most probably independent from the suppression of inflammatory responses and activation-induced cell death. Large-scale in silico analysis of GWAS data confirmed a moderate association between psoriasis and multiple genetic variants in the MIR146A gene. Together, our results confirm miR-146a anti-inflammatory function in the skin and indicate that in case of psoriasis, the expression of miR-146a/b is increased in response to disease-associated cytokines, which then leads to the inhibition of inflammatory responses and hyper-proliferation of keratinocytes through the effect on multiple targets (see also Supplementary Figure S11) .
Previous miRNA profiling studies suggested that the expression of miR-146a/b is increased in the lesional skin of psoriasis patients (Lovendorf et al., 2015; Sonkoly et al., 2007) . We confirmed this result and demonstrated that miR-146a level is elevated in the epidermis and in less extent in the dermis of psoriatic skin, while miR-146b is increased in both the epidermis and the dermis. In human keratinocytes and fibroblasts, the expression of miR-146a was about two-fold higher and was induced by pro-inflammatory cytokines TNF-α, IL-β and IL-17A, while the expression of miR-146b was induced in response to IFN-γ and IL-22 in keratinocytes and in less extent by IL-1β in fibroblasts. This is in line with previous studies demonstrating that the expression of miR-146a is induced by NF-κB and miR-146b is STAT3 and/or STAT1 dependent (Ahn et al., 2013; Curtale et al., 2013) . Among miR-146a target genes that were suppressed in keratinocytes (Rebane et al., 2014) , we detected increased expression of IRAK1, CCL5, IL-8, NUMB and FERMT1 and downregulation of CARD10 in psoriatic plaques when compared to healthy skin. However, there was no correlation of the expression levels of miR-146a/b and the targets in lesional skin samples. This indicates that the expression of miR-146a/b and most of the target genes is modulated by similar cellular signals in the psoriatic skin and suggests that miR-146a/b act through multiple genes and not through a single dominant target. Accordingly, miR-146a has been suggested to suppress proliferation of keratinocytes M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
13 through the targeting of EGFR (Zhang et al., 2014) or IL-8 (Srivastava et al., 2016) . We show here that miR-146a/b also have capacity to inhibit the expression of a positive regulators of keratinocyte proliferation FERMT1 (also known as Kindlin-1) (Herz et al., 2006; Rognoni et al., 2014) and NUMB.
Previously, it has been shown that mutations in the FERMT1 gene cause Kindler syndrome, a progressive cutaneous atrophy characterized by skin blistering, premature skin aging and increased risk of skin cancer (Duperret et al., 2014) . NUMB has been shown to be suppressed by miR-146a in multiple cancers, including melanoma and oral carcinoma (Forloni et al., 2014; Hung et al., 2013 ).
Although we did not find reverse correlation of miR-146a/b and analyzed targets in psoriatic skin, there is strong evidence that endogenous level of miR-146a is sufficient for the suppression of inflammatory responses and that local administration of miR-146a mimics has anti-inflammatory effect in the skin. Accordingly, 146a-/-mice developed more severe disease in mouse models of AD and psoriasis, while pre-injection of miR-146a alleviated the inflammation in mouse models of irritant contact dermatitis and psoriasis (Rebane et al., 2014; Srivastava et al., 2016; Urgard et al., 2016) . As miR-146a/b have similar expression level in vivo in human and mouse skin, miR-146a/b together might have remarkably stronger influence than studies performed with miR-146a-/-mice demonstrate. On the other hand, the observation that the expression of miR-146a/b in normal skin and psoriatic lesions is 10-50-fold lower than that of the most highly expressed miR-203 and miR-125b further supports the therapeutic potential of miR-146a/b overexpression (Lovendorf et al., 2015; Sahmatova et al., 2016) .
It has been shown before (Taganov et al., 2006) and we demonstrate here that miR-146a/b inhibit multiple same targets. However, our experiments do not allow to estimate whether the effects of miR-146a/b are with the same strength. Although in human keratinocytes, the expression level of miR146a/b differed about two times, in cultured mouse keratinocytes, the expression of miR-146a was at least 12-fold higher than that of miR-146b. Accordingly, keratinocytes from miR-146a-/-mice expressed increased levels of Card10, Cxcl1, Fermt1 and Numb in all used conditions, but there was no difference M A N U S C R I P T
14 in keratinocythe from miR-146b-/-mice as compared to WT mice. Although the miR-146b level was apparently 4-fold lower as compared to miR-146a also in mouse skin fibroblasts, the increased expression of miR-146a/b target genes in fibroblasts from miR-146b-/-mice was detected in most conditions. The expression of studied genes in fibroblasts from miR-146a-/-mice was also found to be increased in multiple settings. These results indicate that miR-146a might have more important role in keratinocytes and miR-146b in fibroblasts. Still, further studies are needed to better characterize the roles and functions of the miR-146 family in inflammatory skin diseases and psoriasis.
In line with the results from the functional experiments, our in silico genetic analysis confirmed that there is a suggestive association of genetic variations in miR-146a region and psoriasis, but no association of miR-146b was found. Among the analyzed target genes, only rs7293163 in the CARD10 region showed a significant association with psoriasis. It should be noted that the moderate genetic association with psoriasis might be also due the miR-146a functions in the immune cells, which we did not study here.
In conclusion, the capacity of miR-146a/b simultaneously to inhibit inflammatory responses, activation-induced cell death and proliferation of keratinocytes and fibroblasts suggests that miR-146a/b are mainly pacifying miRNAs that contribute to the skin homeostasis and controlling of inflammatory responses in both healthy and diseased skin. In addition, our results are in line with recently published in vivo mouse studies (Srivastava et al., 2016; Urgard et al., 2016) suggesting that overexpression or local administration of miR-146a/b mimics may have potential for the treatment of psoriasis.
MATERIALS AND METHODS
Patients
30 patients with plaque psoriasis and 30 control subjects were included in the study, of which 22 patient and 22 control samples were used for RT-qPCR analysis (see Supplemental Table S1 ). 8 patient and 8 Association of SNPs in miR146a/b and the target genes (± 50 kb) was analyzed in silico using GWAS data of 4,489 psoriasis cases and 8,240 controls. Details of the meta-analysis have been previously reported (Baurecht et al., 2015) . All participating studies were approved by relevant institutional review boards, and all participants provided written or oral consent. For more detailed description of the study subjects see Supplementary Materials and Methods online.
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Cell culture
Pooled, normal human epidermal keratinocytes (Promocell, Heidelberg, Germany) were cultured in Keratinocyte-SFM with supplements (Life Technologies, Grand Island, NY). Human primary fibroblasts and PBMCs were isolated and cultured as described earlier (Reemann et al., 2014; Tserel et al., 2011) .
Isolation and short-term culture of keratinocytes and fibroblasts was performed according to (Lichti et al., 2008) . For stimulation and transfection conditions see Supplementary Materials and Methods online.
Mouse strains
miR-146a-/-on C57BL/6J background corresponding WT mice were purchased from the Jackson Laboratory (Bar Harbor, Me). The miR-146b-/-mice were generated by deleting genomic sequence that encompasses the miR-146b precursor on mouse chromosome 19. The related animal experiments were approved by the Institutional Animal Care and Use Committee of City of Hope. For more detailed description see Supplementary Materials and Methods online.
Apoptosis, proliferation and luciferase assays
Proliferation was measured using either 
